Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Kobayashi M et al. |
FK 506 assay past and present--characteristics of FK 506 ELISA. |
1991 |
Transplant. Proc. |
pmid:1721258
|
Woodle ES et al. |
Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group. |
1998 |
Transplant. Proc. |
pmid:9636526
|
Youhua Z et al. |
Clinical study of FK 506 in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:11119900
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Büsing M et al. |
Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study. |
1998 |
Transplant. Proc. |
pmid:9532155
|
Shitrit D et al. |
Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. |
2003 |
Transplant. Proc. |
pmid:12644073
|
González E et al. |
Everolimus represents an advance in immunosuppression for patients who have developed cancer after renal transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715911
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506: preclinical and clinical studies. |
1990 |
Transplant. Proc. |
pmid:1689899
|
Crespo-Leiro MG et al. |
Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:11959213
|
Jain AB et al. |
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. |
1990 |
Transplant. Proc. |
pmid:1689900
|
Rajnoch J et al. |
Regulators of angiogenesis in renal ischemia/reperfusion injury in normotensive and hypertensive rats: effect of tacrolimus. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808641
|
Charpentier B |
An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids. |
2001 |
Transplant. Proc. |
pmid:11406262
|
Weir MR |
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation. |
2001 |
Transplant. Proc. |
pmid:11406264
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. |
1993 |
Transplant. Proc. |
pmid:7680173
|
Loréal O et al. |
FK 506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro. |
1991 |
Transplant. Proc. |
pmid:1721289
|
Matsuzaki T et al. |
Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. |
1992 |
Transplant. Proc. |
pmid:1373547
|
McCauley J et al. |
Cyclosporine and FK 506 induced inhibition of renal epithelial cell proliferation. |
1991 |
Transplant. Proc. |
pmid:1721290
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Tashiro H et al. |
Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats. |
2000 |
Transplant. Proc. |
pmid:11120201
|
Ciancio G et al. |
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. |
1996 |
Transplant. Proc. |
pmid:8623473
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Jurewicz WA |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. |
1999 |
Transplant. Proc. |
pmid:10576048
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Bilodeau JF et al. |
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. |
2009 |
Transplant. Proc. |
pmid:19917367
|
Murata M et al. |
Unrelated donor bone marrow transplantation in Japanese patients is facilitated by the National Marrow Donor Program of the United States. |
1998 |
Transplant. Proc. |
pmid:9474987
|
Resch B et al. |
FK 506 and successful pregnancy in a patient after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9474990
|
Reyes J et al. |
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7518137
|
Meiser BM et al. |
Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. |
1993 |
Transplant. Proc. |
pmid:7682363
|
O'Rourke M et al. |
Recovery of delayed-type hypersensitivity following liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533369
|
Fukuzawa M et al. |
Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo. |
1991 |
Transplant. Proc. |
pmid:1721321
|
Foroncewicz B et al. |
Anti-CD25 and tacrolimus therapy may not prevent early primary biliary cirrhosis recurrence after liver transplantation: two case reports. |
2003 |
Transplant. Proc. |
pmid:14529924
|
Kim SW et al. |
Decreased formation of nitric oxide in rats treated with FK506. |
2003 |
Transplant. Proc. |
pmid:12591357
|
Masuda S et al. |
Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919446
|
Tada H et al. |
Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919447
|
Ogino S et al. |
Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15041357
|
Hodge EE et al. |
Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results. |
2002 |
Transplant. Proc. |
pmid:12176477
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Ahlmén J et al. |
Positive effects of tacrolimus in a case of CIDP. |
1998 |
Transplant. Proc. |
pmid:9865344
|
Paul AA et al. |
CMV retinitis and the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721354
|
Larriba J et al. |
Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172323
|
Dahmen U et al. |
Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs. |
2002 |
Transplant. Proc. |
pmid:12270412
|
Gelens MA et al. |
Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus? |
2005 |
Transplant. Proc. |
pmid:15919498
|
Barten MJ et al. |
Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12270442
|
Gaber LW et al. |
Renal histology with varying FK506 blood levels. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122955
|
Takahara S et al. |
Excellent results following 3 years of tacrolimus immunosuppression in kidney transplantation recipients in Japan: overall analysis of more than 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176500
|
Cohen DS et al. |
Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy. |
1996 |
Transplant. Proc. |
pmid:8907923
|
Lorho R et al. |
Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182838
|
Feitoza CQ et al. |
A role for HO-1 in renal function impairment in animals subjected to ischemic and reperfusion injury and treated with immunosuppressive drugs. |
2007 |
Transplant. Proc. |
pmid:17362747
|
Nozaki S et al. |
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. |
1994 |
Transplant. Proc. |
pmid:7520633
|
Sanada O et al. |
Establishment of chimerism in donors by intraportal injection of recipient-type bone marrow cells with concomitant administration of FK 506 before liver transplantation prolongs liver allograft survival in rats. |
1998 |
Transplant. Proc. |
pmid:9838689
|
Morris RE et al. |
Immunopharmacology of FK-506. |
1989 |
Transplant. Proc. |
pmid:2468201
|
Tauxe WN et al. |
A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721386
|
Kandaswamy R et al. |
Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083254
|
Sho M et al. |
Simultaneous inoculation of donor lymphocyte subsets with transplantation in a rat cardiac allograft model. |
1998 |
Transplant. Proc. |
pmid:9838696
|
Yoshimura N et al. |
A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity. |
1989 |
Transplant. Proc. |
pmid:2468202
|
Kramer MR et al. |
Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506). |
1997 |
Transplant. Proc. |
pmid:9290780
|
Tashiro H et al. |
Correlation of high-level microchimerism with graft acceptance in rat liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123287
|
Wijnen RM et al. |
Thymus atrophy in the nonhuman primate by FK506: an immunohistochemical study. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123292
|
Ierardi E et al. |
Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. |
2001 |
Transplant. Proc. |
pmid:11377467
|
Guckelberger O et al. |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? |
1996 |
Transplant. Proc. |
pmid:8962230
|
Jørgensen KA et al. |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176551
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
Braun F et al. |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. |
1996 |
Transplant. Proc. |
pmid:8962231
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Uchida J et al. |
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. |
2012 |
Transplant. Proc. |
pmid:22310596
|
Chen YB et al. |
Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population. |
2011 |
Transplant. Proc. |
pmid:21693271
|
Erickson LM et al. |
Gene expression profiles of rat heart allografts with immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266960
|
Tzakis AG et al. |
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721416
|
Watanabe K et al. |
Immunosuppressive effect of bactobolamine in rat liver allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8658697
|
Meloni F et al. |
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. |
2003 |
Transplant. Proc. |
pmid:12826211
|
Morrissey PE et al. |
Factors contributing to acute rejection in renal transplantation: the role of noncompliance. |
2005 |
Transplant. Proc. |
pmid:15964334
|
Peeters P et al. |
Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group. |
1998 |
Transplant. Proc. |
pmid:9723301
|
Soran A et al. |
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. |
2000 |
Transplant. Proc. |
pmid:10812157
|
Formica RN et al. |
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12742475
|
Polanco N et al. |
Everolimus-based immunosuppression therapy for BK virus nephropathy. |
|
Transplant. Proc. |
pmid:25645770
|
Hasegawa A et al. |
Optimal use of tacrolimus in living donor renal transplantation in children. |
2002 |
Transplant. Proc. |
pmid:12176635
|
Joo DJ et al. |
Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. |
2010 |
Transplant. Proc. |
pmid:21168645
|
Staak A et al. |
Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels. |
2006 |
Transplant. Proc. |
pmid:17175311
|
Moray G et al. |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. |
2006 |
Transplant. Proc. |
pmid:17175334
|
Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Ivulich S et al. |
Clinical Challenges of Tacrolimus for Maintenance Immunosuppression Post-Lung Transplantation. |
2017 |
Transplant. Proc. |
pmid:29149976
|
Davies CB et al. |
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721448
|
Reichenspurner H et al. |
First experience with FK 506 for treatment of chronic pulmonary rejection. |
1995 |
Transplant. Proc. |
pmid:7540775
|
GarcÃa Meseguer C et al. |
The effect of different immunosuppression on the outcome of pediatric renal transplants. |
1999 |
Transplant. Proc. |
pmid:10500577
|
Abu-Elmagd K et al. |
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. |
1991 |
Transplant. Proc. |
pmid:1721449
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Torregrosa JV et al. |
Combined liver-kidney transplantation: our experience. |
1999 |
Transplant. Proc. |
pmid:10500591
|
Morena M et al. |
Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients. |
2000 |
Transplant. Proc. |
pmid:11134805
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1993 |
Transplant. Proc. |
pmid:7689280
|
Fischer S et al. |
Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11134815
|
Dalgic A et al. |
Liver transplantation and tacrolimus monotherapy for hepatocellular carcinoma with expanded criteria. |
2005 |
Transplant. Proc. |
pmid:16213334
|
Hashi S et al. |
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. |
2014 |
Transplant. Proc. |
pmid:24767342
|
Wojarski J et al. |
Immunosuppressive Treatment and Its Effect on the Occurrence of Pneumocystis jiroveci, Mycoplasma pneumoniae, Chlamydophila pnemoniae, and Legionella pneumophila Infections/Colonizations Among Lung Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:30177108
|
Jensik SC |
Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636494
|
Kanatani T et al. |
Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient. |
2004 |
Transplant. Proc. |
pmid:15686745
|